Vanguard Capital Management »

Leap Therapeutics shares owned by Vanguard Capital Management

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by Vanguard Capital Management from 13F filings

Historical chart of Vanguard Capital Management investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Vanguard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 1.8M 0.80